If we look at the chart, we can see that after breaking above the important $10 resistance level, the price sharply rose by 400%.
However, after initially surpassing $40, INJ entered a consolidation phase.
Upon examining the weekly chart, it becomes evident that rallies above $40 were met with selling pressure.
Additionally, yesterday, following a new attempt to exceed $40, the price experienced a significant drop. In my view, these are all signs of a potential reversal.
Technically, as previously mentioned, the $40 zone acts as a strong resistance while $30 serves as a clearly defined support level.
A breach below this support could drive the price down to the next support level at $25. However, given the prolonged distribution around the $40 peak, I wouldn't be surprised to see Injective fall to $20 in the long run.
🎯 Want More Trading Ideas?
📈 Join the FREE Forex & Gold Channel
👉 t.me/intradaytradingsignals
💎Get Funded Up to $1 Million with SabioTrade
Use my exclusive link and get 30% OFF your challenge.
👉shorturl.at/b5yyz
📈 Join the FREE Forex & Gold Channel
👉 t.me/intradaytradingsignals
💎Get Funded Up to $1 Million with SabioTrade
Use my exclusive link and get 30% OFF your challenge.
👉shorturl.at/b5yyz
Publications connexes
Clause de non-responsabilité
Les informations et publications ne sont pas destinées à être, et ne constituent pas, des conseils ou recommandations financiers, d'investissement, de trading ou autres fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
🎯 Want More Trading Ideas?
📈 Join the FREE Forex & Gold Channel
👉 t.me/intradaytradingsignals
💎Get Funded Up to $1 Million with SabioTrade
Use my exclusive link and get 30% OFF your challenge.
👉shorturl.at/b5yyz
📈 Join the FREE Forex & Gold Channel
👉 t.me/intradaytradingsignals
💎Get Funded Up to $1 Million with SabioTrade
Use my exclusive link and get 30% OFF your challenge.
👉shorturl.at/b5yyz
Publications connexes
Clause de non-responsabilité
Les informations et publications ne sont pas destinées à être, et ne constituent pas, des conseils ou recommandations financiers, d'investissement, de trading ou autres fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.
